CNC Insider Trading

Insider Ownership Percentage: 0.33%
Insider Buying (Last 12 Months): $2,660,275.53
Insider Selling (Last 12 Months): $688,346.50

Centene Insider Trading History Chart

This chart shows the insider buying and selling history at Centene by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$2M$0$2MTotal Insider BuyingTotal Insider Selling

Centene Share Price & Price History

Current Price: $59.51
Price Change: Price Increase of +0.174 (0.29%)
As of 03/25/2025 11:40 AM ET

This chart shows the closing price history over time for CNC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$59.38Closing price on 03/24/25:

SEC Filings (Institutional Ownership Changes) for Centene (NYSE:CNC)

93.63% of Centene stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CNC by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$3.67Bbought$2.92BsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$20B-$10B$0$10B$20BTotal InflowsTotal Outflows
Centene logo
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental and speech therapy services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.
Read More on Centene

Today's Range

Now: $59.51
Low: $58.98
High: $59.83

50 Day Range

MA: $60.18
Low: $55.94
High: $65.88

52 Week Range

Now: $59.51
Low: $55.03
High: $80.59

Volume

292,187 shs

Average Volume

4,470,644 shs

Market Capitalization

$29.52 billion

P/E Ratio

9.55

Dividend Yield

N/A

Beta

0.4

Who are the company insiders with the largest holdings of Centene?

Centene's top insider shareholders include:
  1. Sarah London (CEO)
  2. Andrew Lynn Asher (CFO)
  3. Kenneth J Fasola (President)
  4. Christopher J Coughlin (Director)
  5. Theodore R Samuels II (Director)
  6. Thomas Greco (Director)
  7. Lori Jean Robinson (Director)
  8. H James Dallas (Director)
Learn More about top insider investors at Centene.

Who are the major institutional investors of Centene?

Centene's top institutional investors include:
  1. Vanguard Group Inc. — 11.51%
  2. Norges Bank — 5.02%
  3. FMR LLC — 4.24%
  4. Capital World Investors — 3.47%
  5. Wellington Management Group LLP — 3.09%
  6. Geode Capital Management LLC — 2.47%
Learn More about top institutional investors of Centene stock.

Which major investors are selling Centene stock?

During the previous quarter, CNC stock was sold by these institutional investors:
  1. Boston Partners
  2. Capital World Investors
  3. Swedbank AB
  4. Politan Capital Management LP
  5. FMR LLC
  6. Wellington Management Group LLP
  7. Vanguard Group Inc.
  8. Deutsche Bank AG
During the previous year, company insiders that have sold Centene company stock include:
  1. Sarah London (CEO)
  2. Andrew Lynn Asher (CFO)
Learn More investors selling Centene stock.

Which major investors are buying Centene stock?

Within the previous quarter, CNC stock was purchased by institutional investors including:
  1. Norges Bank
  2. AQR Capital Management LLC
  3. Two Sigma Investments LP
  4. Invesco Ltd.
  5. Price T Rowe Associates Inc. MD
  6. Ameriprise Financial Inc.
  7. Assenagon Asset Management S.A.
  8. Two Sigma Advisers LP
During the last year, these company insiders have bought Centene stock:
  1. Sarah London (CEO)
  2. Andrew Lynn Asher (CFO)
  3. Kenneth J Fasola (President)
  4. Christopher J Coughlin (Director)
  5. Theodore R Samuels II (Director)
Learn More investors buying Centene stock.